Kirin Holdings Company, Limited has invested in Irish healthtech startup FoodMarble Digestive Health Ltd through its corporate venture capital arm, KIRIN VENTURES. The investment was completed on September 30, 2026. FoodMarble develops breath-testing devices and an app that help people monitor their digestive health.
First investment under KIRIN VENTURES
The deal marks the first startup investment under KIRIN VENTURES, which launched in 2026. Kirin has conducted venture capital activities since 2020 through its KIRIN HEALTH INNOVATION FUND and other initiatives. The new investment program targets startups across health science, food, lifestyle, digital technology, and sustainability.
About FoodMarble
Founded in Dublin, Ireland, in 2015, FoodMarble is led by CEO Aonghus Shortt. The company serves consumers in Europe and North America, including the United States and the United Kingdom. Its digital health platform combines breath analysis with meal and symptom tracking to help users understand their digestive health.
How the technology works
FoodMarble offers a palm-sized device that measures gases in exhaled breath produced by intestinal fermentation. Users can take measurements at home and record the results through a dedicated app. The platform combines these readings with food and symptom records to help identify relationships between diet and digestive health.
Kirin plans to explore collaboration in Japan by combining its expertise in fermentation, ingredients, and gut health with FoodMarble's technology and data. The initial focus will be on developing new digestive health services. FoodMarble also plans to expand its self-care features using data and AI.